Third‐Trimester Maternal Serum Chemerin and Hypertension After Preeclampsia: A Prospective Cohort Study
Journal of the American Heart Association · 07.03.2023 · 12 (5)
DOI: 10.1161/jaha.122.027930 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 07.03.2023. Verfasst von Yixuan Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics Shenzhen Maternity and Child Healthcare Hospital Shenzhen Guangdong China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Hypertension. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background Limited data are available for postpartum hypertension prediction after preeclampsia. Methods and Results We examined the association between maternal serum chemerin levels in patients with preeclampsia and blood pressure (BP) levels after delivery in a prospective birth cohort of 15 041 singleton pregnant women. A total of 310 cases among 322 patients with preeclampsia (follow‐up rate, 96.3%) were followed up during a mean 2.8 years after delivery. Compared with matched uncomplicated controls (n=310), serum chemerin measured at ≈35 gestational weeks was significantly increased in preeclampsia (171.8±49.2 versus 140.2±53.5 ng/mL; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics Shenzhen Maternity and Child Healthcare Hospital Shenzhen Guangdong China.
- The First School of Clinical Medicine Southern Medical University Shenzhen Guangdong China.
- Department of Obstetrics and Gynecology, the Eighth Affiliated Hospital Sun Yat-sen University Shenzhen Guangdong China.
- Department of Cardiology Tianjin Medical University General Hospital Tianjin China.
ORCID-Profile: Yixuan Chen, Aiqi Yin, Cuiping Zeng, Yanmei Wan, Qing Yang, Xin Zhou, Jianmin Niu
Zitieren
APA
Chen, Y., Wu, L., Liu, H., Li, Z., Li, L., Wu, X., Lei, Q., Yin, A., Tong, J., Liu, K., Guan, X., Zeng, C., Zhang, H., Wan, Y., Huang, X., Huang, P., Yang, Q., Zhou, X., & Niu, J. (2023). Third‐Trimester Maternal Serum Chemerin and Hypertension After Preeclampsia: A Prospective Cohort Study. Journal of the American Heart Association, 12(5). https://doi.org/10.1161/jaha.122.027930
Vancouver
Chen Y, Wu L, Liu H, Li Z, Li L, Wu X, et al. Third‐Trimester Maternal Serum Chemerin and Hypertension After Preeclampsia: A Prospective Cohort Study. Journal of the American Heart Association. 2023;12(5). doi:10.1161/jaha.122.027930
BibTeX
@article{Chen2023,
author = {Chen, Yixuan and Wu, Linlin and Liu, Hangkuan and Li, Ziping and Li, Linjie and Wu, Xiaoxia and Lei, Qiong and Yin, Aiqi and Tong, Jianing and Liu, Kan and Guan, Xiaonian and Zeng, Cuiping and Zhang, Huafan and Wan, Yanmei and Huang, Xuna and Huang, Pingping and Yang, Qing and Zhou, Xin and Niu, Jianmin},
title = {Third‐Trimester Maternal Serum Chemerin and Hypertension After Preeclampsia: A Prospective Cohort Study},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {5},
doi = {10.1161/jaha.122.027930}
}
EUVIMED